Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature reviewReview Published on 2023-02-012023-06-01 Journal: Seminars in arthritis and rheumatism [Category] [DOI] 10.1016/j.semarthrit.2022.152120 PMC 바로가기 [Article Type] Review
Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia: a systematic review and meta-analysisMeta-Analysis Published on 2022-10-012023-07-10 Journal: Expert review of respiratory medicine [Category] [DOI] 10.1080/17476348.2022.2114899 PMC 바로가기 [Article Type] Meta-Analysis
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patientsArticle Published on 2022-09-292022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.1017863 PMC 바로가기
Rheumatoid arthritis patients treated with Janus kinase inhibitors show reduced humoral immune responses following BNT162b2 vaccinationJanus kinase inhibitor로 치료받은 류마티스 관절염 환자, BNT162b2 백신 접종 후 체액성 면역 반응 감소Article Published on 2022-08-032022-09-12 Journal: Rheumatology (Oxford, England) [Category] [DOI] 10.1093/rheumatology/keab879 PMC 바로가기 [Article Type] Article
JAK inhibition as a new treatment strategy for patients with COVID-19Review article Published on 2022-08-012022-10-05 Journal: Biochemical pharmacology [Category] [DOI] 10.1016/j.bcp.2022.115162 [Article Type] Review article
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysisCOVID-19로 병원에 입원한 환자의 바리시티닙(RECOVERY): 무작위, 통제, 공개 라벨, 플랫폼 시험 및 업데이트된 메타 분석Meta-Analysis Published on 2022-07-302022-09-11 Journal: Lancet (London, England) [Category] [DOI] 10.1016/S0140-6736(22)01109-6 PMC 바로가기 [Article Type] Meta-Analysis
JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoidsJAK 억제제는 사구체 세포에서 COVID-19 사이토카인 유도 JAK/STAT/APOL1 신호전달 및 인간 신장 오르가노이드에서 족세포병증을 차단합니다Article Published on 2022-06-082022-09-11 Journal: JCI Insight [Category] [DOI] 10.1172/jci.insight.157432 PMC 바로가기 [Article Type] Article
Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitorsArticle Published on 2022-06-012023-05-31 Journal: Clinical Rheumatology [Category] [DOI] 10.1007/s10067-022-06096-0 PMC 바로가기
Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection Research Published on 2022-05-122022-10-05 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-022-11879-1 [Article Type] Research
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trialsCOVID-19로 입원한 환자를 위한 Janus kinase inhibitors: 무작위 대조 시험의 메타 분석Meta-Analysis Published on 2022-05-012022-09-11 Journal: Expert review of anti-infective therapy [Category] [DOI] 10.1080/14787210.2022.2004120 PMC 바로가기 [Article Type] Meta-Analysis